1,2:3,4-DIBENZANTHRACENE
![1,2:3,4-DIBENZANTHRACENE Structure](CAS/GIF/215-58-7.gif)
- CAS No.
- 215-58-7
- Chemical Name:
- 1,2:3,4-DIBENZANTHRACENE
- Synonyms
- Db(a,c)A;1,2:3,4-DBA;Benztriphenylene;benzotriphenylene;Benzo[f]tetraphene;BENZO[B]TRIPHENYLENE;2,3-BENZTRIPHENYLENE;2,3-benzotriphenylene;DIBENZ[A,C]ANTHRACENE;Zavegepant Impurity 8
- CBNumber:
- CB3316528
- Molecular Formula:
- C22H14
- Molecular Weight:
- 278.35
- MOL File:
- 215-58-7.mol
- MSDS File:
- SDS
- Modify Date:
- 2023/5/4 17:34:35
Melting point | 205-207 °C(lit.) |
---|---|
Boiling point | 518 °C(lit.) |
Density | 1.1489 (estimate) |
refractive index | 1.8120 (estimate) |
Flash point | -18 °C |
storage temp. | Sealed in dry,2-8°C |
solubility | Chloroform (Slightly), Ethyl Acetate (Slightly), DMSO (Slightly) |
color | Clear plates, leaflets or needles from EtOH orAcOH |
Water Solubility | 1.6ug/L(25 ºC) |
BRN | 1912415 |
CAS DataBase Reference | 215-58-7(CAS DataBase Reference) |
IARC | 3 (Vol. Sup 7, 92) 2010 |
EPA Substance Registry System | Dibenz[a,c]anthracene (215-58-7) |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() ![]() GHS06,GHS09 |
---|---|
Signal word | Danger |
Hazard statements | H301-H311-H331-H400 |
Precautionary statements | P261-P273-P280-P301+P310-P311 |
Hazard Codes | T,N,Xn,F |
Risk Statements | 23/24/25-50-67-65-50/53-38-11 |
Safety Statements | 36/37-45-61-62-60 |
RIDADR | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | DM1925000 |
HazardClass | 6.1(b) |
PackingGroup | III |
HS Code | 29029000 |
Toxicity | mma-sat 10 mg/plate PNASA6 72,5135,75 |
1,2:3,4-DIBENZANTHRACENE Chemical Properties,Uses,Production
Chemical Properties
LIGHT YELLOW TO BROWN POWDER
Uses
Dibenzo[a,c]anthracene is a polycyclic aromatic hydrocarbon which are known carcinogens and environmental pollutants.
Safety Profile
Questionable carcinogen withexperimental tumorigenic data. Human mutation datareported. When heated to decomposition it emits acridsmoke and irritating fumes.
Carcinogenicity
Dibenz[a,c]anthracene was administered dermally to mice, either per se or as part of initiation–promotion protocols. The working group concluded that there was limited evidence for animal carcinogenicity. In later studies on an initiation–promotion study on mouse skin, low initiating doses gave negative results when administered subcutaneously to mice, and tumor incidence was not significantly increased over that observed in controls when the compound was administered intraperitoneally to newborn mice.
1,2:3,4-DIBENZANTHRACENE Preparation Products And Raw materials
1,2:3,4-DIBENZANTHRACENE Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
Aladdin Scientific | +1-+1(833)-552-7181 | United States | 52927 | 58 | Inquiry |
Amadis Chemical Company Limited | 571-89925085 | China | 131980 | 58 | Inquiry |
ABCR GmbH & CO. KG | 49 721 95061 0 | Germany | 6846 | 75 | Inquiry |
LGC Standards | +44 (0)20 8943 8480 | United Kingdom | 6495 | 0 | Inquiry |
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. | 025-66099280 17798518460 | China | 19918 | 55 | Inquiry |
Shanghai Hao Zhun Biological Technology Co., Ltd. | 15800340161 | CHINA | 6846 | 58 | Inquiry |
Qingdao Tenglong microwave technology co., LTD. | 0532-83818797 18561885118 | China | 3946 | 58 | Inquiry |
Sigma-Aldrich | 021-61415566 800-8193336 | China | 51471 | 80 | Inquiry |
Portail Substances Chimiques | 10 20 0000 | France | 6027 | 58 | Inquiry |
215-58-7(1,2:3,4-DIBENZANTHRACENE)Related Search:
1of4
chevron_right